To further investigate the role of DOCK1 in BC cisplatin resistance, Western blotting was used to observe changes in the level of E-cadherin and Vimentin protein expression in DOCK1-siRNA-treated BC cells exposed to cisplatin. This evidence concerns the gene DOCK1 and breast cancer.